prmitteilung.de
Das Kostenlose Presseportal für Pressemeldungen. Schreiben oder veröffentlichen Sie eine Pressemitteilung auf prmitteilung.de

The hormone replacement therapy market is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end. Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

Disorders associated with hormonal imbalance continue to influence the use of hormone replacement therapy worldwide. Hormone replacement therapy demand is further pushed with macroeconomic aspects such as growing geriatric population and significant increase in healthcare expenditure worldwide. Growing age directly impacts secretion of hormones such as progesterone and estrogen in women, which is expected to trigger the use of estrogen hormone replacement therapy.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

Global sales of histopathology testing equipment surpassed US$ 5,300 Mn in 2017, with consumables leading the growth, according to the findings of a recently published study by Fact.MR.

Rising incidences of cancer and associated mortalities are driving the need for efficient tissue diagnosis. Moreover, growing inclination toward less-invasive diagnostic procedures for cancer and other malignancies drove growth of histopathology testing equipment.

“The American Cancer Society and National Center for Health Statistics have revealed that cancer cases in Unite States crossed 1,685,000 in 2017 and are likely to increase in the coming years. Likewise, according to WHO (World Health Organization) report, emerging economies such as India are witnessing an increase in cancer mortality rates with India reflecting 79 per 100,000 deaths. This has pushed the demand for efficient diagnosis of the disease, which is expected to translate into an increase in histopathology testing equipment sales crossing US$ 5,500 Mn by end of 2018”. – Lead Analyst, Fact.MR Medical Diagnostics Division

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

Cancer profiling market revenues surpassed US$ 900 million in 2018, according to Fact.MR’s latest study. Growing at a subdued 4% y-o-y, the study foresees absolute opportunity of over US$ 36 million in 2019. Steadily rising opportunities in cancer profiling market can be attributed to,

Increasing disease burden of cancer worldwide
Significant economic burden associated with cancer diagnosis and treatment
Growing R&D investments to develop effective cancer diagnostics
Increasing importance of precision medicine adoption and reliance of cancer profiling
According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=358

S/4HANA, SAP Fiori 3, SAP Cloud Platform und Digital Workplace - mit SAP konsequent in die Zukunft

VANTAiO auf dem DSAG Jahreskongress 2019

Unter dem Motto "Und Action! Digitalisierung konsequent machen" machte der DSAG Jahreskongress 2019 vom 17. bis 19.9. in Nürnberg Unternehmen Mut, die digitale Transformation als Chance zu begreifen und sich ihren Herausforderungen zu stellen. Erneut gab es einen Teilnehmerrekord zu verzeichnen, über 5.500 Besucher nahmen am weltweit wichtigsten SAP-Anwendertreffen teil. Auch wir waren wieder dabei - und das waren unsere Eindrücke und Top-Themen:

ULTRASONE bietet ein Affiliate-Programm für Medienpartner und Influencer

Wielenbach, 26. September 2019 - Mit einem neuen Affliliate-Programm unterstützt der bayerische Kopfhörerhersteller ULTRASONE Medienpartner und Markenbotschafter wie Social-Media-Influencer, Blogger und Online-Fachmedien. Nach der Online-Anmeldung können alle Teilnehmer des Affiliate-Programms an jedem über ihren personalisierten Affiliate-Link verkauften ULTRASONE Kopfhörer mitverdienen.

Mit dem ULTRASONE Affiliate-Programm direkt profitieren
Der bayerische Kopfhörerhersteller ULTRASONE ist stolz auf die gute Beziehung zu Fachmedien und Influencern aus Bereichen wie Technik, Audio und Kopfhörer. Das neue Affiliate-Programm gibt Medienpartnern und Markenbotschaftern die Möglichkeit, direkt vom Erfolg der eigenen Berichterstattung über ULTRASONE zu profitieren: Über einen personalisierten Affiliate-Link werden die Teilnehmer des Programms an darüber verkauften Produkten beteiligt und bekommen 5 Prozent des Netto-Umsatzes. So unterstreicht ULTRASONE das eigene Bekenntnis zu einer guten Partnerschaft mit Medien und Influencern.

ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to,

Technological advancements enhancing ENT procedure efficiency and outcome
Reimbursement policies in favor of ENT surgeries
Product developments accommodating demand trend such as minimal invasion
The medical technology industry has shifted from a traditional marketing model to a care delivery model. Following the new business approach, Tier 1 and Tier 2 players portray hegemony in the market and continue to introduce disruptive technology innovations in ENT surgical devices.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

The ENT surgical devices marketplace has the presence of a broad range of surgical instruments and equipment. According to Fact.MR valuation, ENT surgical lasers account for a leading share in the global market.

ENT diagnostic devices market is estimated to hit US$ 2.3 billion in 2019, according to a new study by Fact.MR. The market grew at 6.3% y-o-y in 2018 with bronchoscopes accounting for nearly one third of the global revenues. Overall growth of the ENT diagnostic devices market can be attributed to,

Advanced technology incorporations in ENT diagnostic devices
Favorable reimbursement policies for ENT procedures
Development of efficient and low-priced devices
According to Fact.MR study, the ENT endoscopes are estimated to account for over half the revenues of the ENT diagnostic devices market in 2019. Endoscopy has played a significant role in the diagnosis of ear, nose and throat related diseases as well as successful treatment outcomes. Owing to this, ENT endoscopes have become the most common devices in the ENT clinics.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2468

Die Engagement-Plattform Connect bietet BCD-Kunden Zugang zu Tools, Schulungsmaterial und Brancheninfos und macht den Austausch innerhalb der Geschäftsreise-Community möglich

Utrecht, 26. September 2019 - BCD Travel, eine der weltweit führenden Travel Management Companies weltweit, hat mit Connect eine digitale Engagement-Plattform exklusiv für BCD-Kunden eingeführt. Mit diesem Schritt investiert BCD weiter in digitale Engagement-Dienstleistungen. Connect bietet eine Community-Umgebung, die den Mehrwert von Geschäftsreiseprogrammen und die Zusammenarbeit zwischen BCD und Kunden weltweit fördert. Connect bietet nicht nur die Möglichkeit zum Austausch innerhalb von Diskussionsgruppen, es dient auch als Quelle für Best Practices, Produkt-Updates und Case Studies, Studien und White Paper, Branchentrends, Support, Account-Details und mehr.

Im Fokus des Live Webinars stehen die neuen Connectivity-Funktionen

Alzenau, 26. September 2019 - Seit gestern ist MindManager® 2020 für Windows auf dem Markt und gleich am 1. Oktober gibt es ein Webinar zur neuen Version der marktführenden Mindmapping Software. Die Teilnahme empfiehlt sich für jeden, der sich für das neue Release interessiert oder es bereits im Einsatz hat.

In Zeiten einer zunehmenden Informationsflut und heterogenen Zusammenarbeit spielt das Sammeln und Teilen von Wissen sowie die Vernetzung der Menschen eine immer wichtigere Rolle. Nach dem Motto "Connecting people. Connecting data. Connecting platforms" setzt hier die neue Version von MindManager 2020 für Windows an und bietet neue Möglichkeiten, Menschen zu verbinden, Daten zu teilen und die Zusammenarbeit zu erleichtern.

Growing emphasis on early detection and prevention is driving the melanoma cancer diagnostics market, with global revenue surpassing US$ 800 million in 2018, according to a new study conducted by Fact.MR. The growth of the market is steady in countries/regions with higher prevalence of melanoma. Spending on advanced and safe melanoma cancer diagnostics is growing in the US, as efforts to diagnose the disease at an early stage gain traction. The American Academy of Dermatology estimates around 9,500 people in the US are diagnosed with skin cancer and more than 1 million people in the US are living with melanoma. With skin cancer as most common form of cancer in the US, an increasing number of people are receiving skin cancer diagnosis every year compared to other type of cancers.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=57

Extensive usage of tanning beds is also leading to the rise in melanoma cancer rates globally. Researchers have also found that UV light from sun and tanning beds not only causes melanoma but increases the risk of benign mole which can progress to melanoma. Europe also shows potential for expansion in melanoma cancer diagnostics owing to the treatment rates, government initiatives supporting diagnosis and treatment, and availability of premium drugs.